Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.

Attorneys general in 22 states filed a lawsuit against the Trump administration Feb. 10, aiming to block significant cuts to federal grant funding for medical research projects.

United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...

Many people are involved in the remarkable range of programs, services and facilities that undergird research in the College of Agriculture. Collectively they’re integral to the college fulfilling its ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

For four years, Justin Frye and Jason Funaro were good friends. Frye, a Physician Assistant in Infectious Diseases since 2016 ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or pharmacy.

Kuwait City – The American Chamber of Commerce in Kuwait (AmCham Kuwait) in collaboration with the National Center for ...

Leaders of several rural hospitals and health care clinics joined in urging the Banking, Commerce and Insurance Committee to endorse North Platte Sen. Mike Jacobson's Legislative Bill 527 and Gering ...

Education forms the foundation of a nation's progress, equipping individuals with the knowledge and skills to drive ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

The lawsuit represents the strongest rebuke at the state level of Trump’s executive order targeting transgender healthcare.